1
|
Ahmed I, Ahamed R, Nahar S, Bari LF, Dewan SMR. Immunization against dengue virus infection is coercive: A timely call. Health Sci Rep 2024; 7:e2170. [PMID: 38845788 PMCID: PMC11154804 DOI: 10.1002/hsr2.2170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Revised: 03/26/2024] [Accepted: 05/21/2024] [Indexed: 06/09/2024] Open
Abstract
Background In context, the dengue virus causes dengue fever, which is spread by mosquito bites. About 22,000 people every year lose their lives as a direct result of it. Dengue fever has been on the rise recently, and its spread has alarmed health officials throughout the world. Discussion Vaccination is essential for the prevention and management of dengue cases because there is currently no particular cure against dengue virus. The current dengue epidemic calls for urgent action in the form of immunization. However, there are serious drawbacks to using existing vaccines like Dengvaxia. Besides, the Qdenga vaccine has not yet been approved by the FDA in the United States. On the other hand, positive results from a phase II randomized and controlled clinical study of the TV005 tetravalent live-attenuated dengue vaccine were recently reported in Bangladesh. Only an effective vaccination can drastically lower dengue infection and mortality rates. Conclusion The development of safe and effective vaccination, as well as their correct dissemination, is an essential requirement for the people of Bangladesh and the rest of the globe, and we concentrated on this critical problem in this article.
Collapse
Affiliation(s)
- Iftekhar Ahmed
- Department of Pharmacy, School of MedicineUniversity of Asia PacificDhakaBangladesh
| | - Rayhan Ahamed
- Department of Pharmacy, School of MedicineUniversity of Asia PacificDhakaBangladesh
| | - Shamsun Nahar
- Department of Pharmacy, School of MedicineUniversity of Asia PacificDhakaBangladesh
| | - Lazima F. Bari
- Department of Pharmacy, School of MedicineUniversity of Asia PacificDhakaBangladesh
| | - Syed M. R. Dewan
- Department of Pharmacy, School of MedicineUniversity of Asia PacificDhakaBangladesh
| |
Collapse
|
2
|
Chen X, Wang M, Liu X, Zhang W, Yan H, Lan X, Xu Y, Tang S, Xie J. Clustering analysis for the evolutionary relationships of SARS-CoV-2 strains. Sci Rep 2024; 14:6428. [PMID: 38499639 PMCID: PMC10948388 DOI: 10.1038/s41598-024-57001-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Accepted: 03/13/2024] [Indexed: 03/20/2024] Open
Abstract
To explore the differences and relationships between the available SARS-CoV-2 strains and predict the potential evolutionary direction of these strains, we employ the hierarchical clustering analysis to investigate the evolutionary relationships between the SARS-CoV-2 strains utilizing the genomic sequences collected in China till January 7, 2023. We encode the sequences of the existing SARS-CoV-2 strains into numerical data through k-mer algorithm, then propose four methods to select the representative sample from each type of strains to comprise the dataset for clustering analysis. Three hierarchical clustering algorithms named Ward-Euclidean, Ward-Jaccard, and Average-Euclidean are introduced through combing the Euclidean and Jaccard distance with the Ward and Average linkage clustering algorithms embedded in the OriginPro software. Experimental results reveal that BF.28, BE.1.1.1, BA.5.3, and BA.5.6.4 strains exhibit distinct characteristics which are not observed in other types of SARS-CoV-2 strains, suggesting their being the majority potential sources which the future SARS-CoV-2 strains' evolution from. Moreover, BA.2.75, CH.1.1, BA.2, BA.5.1.3, BF.7, and B.1.1.214 strains demonstrate enhanced abilities in terms of immune evasion, transmissibility, and pathogenicity. Hence, closely monitoring the evolutionary trends of these strains is crucial to mitigate their impact on public health and society as far as possible.
Collapse
Affiliation(s)
- Xiangzhong Chen
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China
| | - Mingzhao Wang
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China
| | - Xinglin Liu
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China
| | - Wenjie Zhang
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China
| | - Huan Yan
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China
| | - Xiang Lan
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China
| | - Yandi Xu
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China
- College of Life Sciences, Shaanxi Normal University, Xian, 710119, China
| | - Sanyi Tang
- School of Mathematics and Statistics, Shaanxi Normal University, Xian, 710119, China.
| | - Juanying Xie
- School of Computer Science, Shaanxi Normal University, Xian, 710119, China.
| |
Collapse
|
3
|
Wang Y, Yu G, Shi J, Zhang X, Huo J, Li M, Chen J, Yu L, Li Y, Han Z, Zhang J, Ren X, Wang Y, Yuntana W. Retrospective study about clinical severity and epidemiological analysis of the COVID-19 Omicron subvariant lineage-infected patients in Hohhot, China. BMC Infect Dis 2024; 24:206. [PMID: 38360539 PMCID: PMC10870667 DOI: 10.1186/s12879-024-09084-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 02/01/2024] [Indexed: 02/17/2024] Open
Abstract
BACKGROUND Fear of a global public health issue and fresh infection wave in the persistent COVID-19 pandemic has been enflamed by the appearance of the novel variant Omicron BF.7 lineage. Recently, it has been seeing the novel Omicron subtype BF.7 lineage has sprawled exponentially in Hohhot. More than anything, risk stratification is significant to ascertain patients infected with COVID-19 who the most need in-hospital or in-home management. The study intends to understand the clinical severity and epidemiological characteristics of COVID-19 Omicron subvariant BF.7. lineage via gathering and analyzing the cases with Omicron subvariant in Hohhot, Inner Mongolia. METHODS Based upon this, we linked variant Omicron BF.7 individual-level information including sex, age, symptom, underlying conditions and vaccination record. Further, we divided the cases into various groups and assessed the severity of patients according to the symptoms of patients with COVID-19. Clinical indicators and data might help to predict disadvantage outcomes and progression among Omicron BF.7 patients. RESULTS In this study, in patients with severe symptoms, some indicators from real world data such as white blood cells, AST, ALT and CRE in patients with Omicron BF.7 in severe symptoms were significantly higher than mild and asymptomatic patients, while some indicators were significantly lower. CONCLUSIONS Above results suggested that the indicators were associated with ponderance of clinical symptoms. Our survey emphasized the value of timely investigations of clinical data obtained by systemic study to acquire detailed information.
Collapse
Affiliation(s)
- Yanhai Wang
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Guohui Yu
- Hohhot Dian Medical Laboratory, Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Dian Diagnostics Group Co., Ltd. No, 329 Jin Peng Street, Xihu District, Hangzhou, Zhejiang Province, 310030, China
| | - Jingru Shi
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Xiaqing Zhang
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Jianxin Huo
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Meng Li
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Jiaxi Chen
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Liyuan Yu
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Yan Li
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Zhiliang Han
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Jianwen Zhang
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Xuna Ren
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Yujie Wang
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China
| | - Wu Yuntana
- Clinical Laboratory Department, Hohhot First Hospital, Hohhot, 010000, China.
| |
Collapse
|
4
|
Roknuzzaman ASM, Sarker R, Nazmunnahar, Shahriar M, Mosharrafa RA, Islam MR. The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts. CLINICAL PATHOLOGY (THOUSAND OAKS, VENTURA COUNTY, CALIF.) 2024; 17:2632010X241228053. [PMID: 38264675 PMCID: PMC10804921 DOI: 10.1177/2632010x241228053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Accepted: 12/22/2023] [Indexed: 01/25/2024]
Affiliation(s)
- ASM. Roknuzzaman
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Rapty Sarker
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Nazmunnahar
- Department of Sociology, Eden Women’s College, National University Bangladesh, Gazipur, Bangladesh
| | - Mohammad Shahriar
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Rana Al Mosharrafa
- Department of Business Administration, Faculty of Business Studies, Prime University, Dhaka, Bangladesh
| | | |
Collapse
|
5
|
Bari LF, Ahmed I, Ahamed R, Zihan TA, Sharmin S, Pranto AH, Islam MR. Potential Use of Artificial Intelligence (AI) in Disaster Risk and Emergency Health Management: A Critical Appraisal on Environmental Health. ENVIRONMENTAL HEALTH INSIGHTS 2023; 17:11786302231217808. [PMID: 38089525 PMCID: PMC10712270 DOI: 10.1177/11786302231217808] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/21/2023] [Accepted: 11/08/2023] [Indexed: 04/19/2024]
Abstract
The risk evaluation of natural disasters is an obstacle to ensuring healthcare services during catastrophic events worldwide. Therefore, timely and appropriate environmental health risk evaluation is essential. In this study, we incorporated the information from databases such as PubMed, Google Scholar, and Scopus. We performed this study to explore the feasibility of using artificial intelligence (AI) in disaster risk and emergency health management. Natural disasters have some phenomenon that is bound to happen. So, we can use AI to inform healthcare authorities about environmental health risks and emergency medical management. The recent innovations in technology have created novel opportunities for improving healthcare services across the world. AI technology would be the backbone of the fourth industrial revolution because we are entering an AI-based world this decade. Therefore, we suggest the authorities consider this positive aspect of AI technology to minimize the disastrous outcomes of any catastrophic events.
Collapse
Affiliation(s)
- Lazima Faiah Bari
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Iftekhar Ahmed
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Rayhan Ahamed
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Tawhid Ahmed Zihan
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Sabrina Sharmin
- School of Pharmacy, BRAC University, Progati Sarani, Merul Badda, Dhaka, Bangladesh
| | - Abir Hasan Pranto
- Department of Pharmacy, University of Asia Pacific, Farmgate, Dhaka, Bangladesh
| | - Md. Rabiul Islam
- School of Pharmacy, BRAC University, Progati Sarani, Merul Badda, Dhaka, Bangladesh
| |
Collapse
|
6
|
Sarker R, Roknuzzaman ASM, Nazmunnahar, Shahriar M, Hossain MJ, Islam MR. The WHO has declared the end of pandemic phase of COVID-19: Way to come back in the normal life. Health Sci Rep 2023; 6:e1544. [PMID: 37674622 PMCID: PMC10478644 DOI: 10.1002/hsr2.1544] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Accepted: 08/22/2023] [Indexed: 09/08/2023] Open
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has resulted in significant global mortality and morbidity affecting millions of lives. As healthcare authorities worldwide are still paying substantial attention to COVID-19, other diseases continue to cause more deaths than COVID-19. The decreasing number of COVID-19 cases and deaths indicates that the pandemic is close to the end. For effective pandemic management, healthcare facilities worldwide have established COVID-19 units and testing facilities, instituting infection prevention and control measures, and employing telehealth services. Healthcare professionals have identified some promising treatments for COVID-19; also, mass vaccinations have improved patient outcomes. Instead of COVID-19 as a pandemic, it is time to pay more attention to other diseases to lessen their impact on public health. Therefore, the World Health Organization (WHO) has declared the end of the pandemic phase of COVID-19 considering the current COVID-19 situation and our preparedness, past pandemic experience, and long pandemic impact on social and economic life on May 5, 2023. In this article, we briefly discussed the present challenges due to COVID-19, necessary precautions, and future directions to return to life as before COVID-19.
Collapse
Affiliation(s)
- Rapty Sarker
- Department of PharmacyUniversity of Asia PacificDhakaBangladesh
| | | | - Nazmunnahar
- Department of Sociology, Eden Women's CollegeNational University BangladeshGazipurBangladesh
| | | | | | - Md. Rabiul Islam
- Department of PharmacyUniversity of Asia PacificDhakaBangladesh
- School of PharmacyBRAC UniversityDhakaBangladesh
| |
Collapse
|
7
|
Nazmunnahar, Ahmed I, Roknuzzaman ASM, Islam MR. The recent Nipah virus outbreak in Bangladesh could be a threat for global public health: A brief report. Health Sci Rep 2023; 6:e1423. [PMID: 37448729 PMCID: PMC10336337 DOI: 10.1002/hsr2.1423] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 06/22/2023] [Accepted: 07/02/2023] [Indexed: 07/18/2023] Open
Abstract
The Nipah virus is a zoonotic infection that can potentially be transmitted from person to person as well as through ingesting contaminated food. It has a high fatality rate, and no treatment or cure at present. Several nations in South Asia have reported Nipah virus outbreaks occurred during a particular season of the year. Since it was first found in Bangladesh in 2001, there have been a total of 335 people infected with it, and 237 of those people have passed away as a result of their infection. With increased public awareness, community engagement, and preventative measures, this potentially fatal virus has been suppressed. Yet, following a pandemic and a considerable increase in the health burden, the transmission rate continuously increased over a few years, indicating that there is a growing possibility to become a global public health concern. Without effective vaccines and reliable treatment options, its capacity for human-to-human transmission and potential to spread throughout the area could result in a disastrous public health emergency worldwide.
Collapse
Affiliation(s)
- Nazmunnahar
- Department of Sociology, Eden Women's CollegeNational University BangladeshGazipurBangladesh
| | - Iftekhar Ahmed
- Department of PharmacyUniversity of Asia PacificDhakaBangladesh
| | | | | |
Collapse
|
8
|
Islam MR, Haque MA, Ahamed B, Tanbir M, Khan MR, Eqbal S, Rahman MA, Shahriar M, Bhuiyan MA. Assessment of vaccine perception and vaccination intention of Mpox infection among the adult males in Bangladesh: A cross-sectional study findings. PLoS One 2023; 18:e0286322. [PMID: 37289746 PMCID: PMC10249809 DOI: 10.1371/journal.pone.0286322] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Accepted: 05/13/2023] [Indexed: 06/10/2023] Open
Abstract
BACKGROUND Mpox (monkeypox) infection has become a global concern for healthcare authorities after spreading in multiple non-endemic countries. Following the sudden multi-country outbreak of Mpox, the World Health Organization (WHO) declared a public health emergency of international concern. We do not have any vaccines approved for the prevention of Mpox infection. Therefore, international healthcare authorities endorsed smallpox vaccines for the prevention of Mpox disease. Here we intended to perform this cross-sectional study among the adult males in Bangladesh to assess the Mpox vaccine perception and vaccination intention. METHODS We conducted this web-based survey among the adult males in Bangladesh from September 1, 2022, to November 30, 2022, using Google Forms. We assessed the Mpox vaccine perception and vaccination intention. We performed a chi-square test to compare vaccine perception and vaccination intention levels. Also, we performed multiple logistic regression analyses to determine the association between the study parameters and the sociodemographic profile of the participants. RESULTS According to the present study, the Mpox vaccine perception was high among 60.54% of the respondents. Also, 60.05% of respondents showed medium vaccination intention. Mpox vaccine perception and vaccination intention were strongly associated with the sociodemographic profiles of the participants. Furthermore, we discovered a significant association between the level of education and vaccination intention among the respondents. Also, age and marital status played a role in the Mpox vaccine perception and vaccination intention. CONCLUSION Our findings showed a significant association between sociodemographic characteristics and the Mpox vaccine perception/vaccination intention. Along with the country's long experience in mass immunization, campaigns about Covid-19 vaccines and high vaccination rates might play a role in Mpox vaccine perception and vaccination intention. We recommend more social awareness and educational communications or seminars for the target population to bring more positive changes in their attitude towards Mpox prevention.
Collapse
Affiliation(s)
- Md. Rabiul Islam
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Md. Anamul Haque
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Bulbul Ahamed
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Md. Tanbir
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Md. Robin Khan
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Saba Eqbal
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Md. Ashrafur Rahman
- Department of Pharmaceutical Sciences, Wilkes University, Wilkes Barre, PA, United States of America
| | - Mohammad Shahriar
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | | |
Collapse
|
9
|
Haque MA, Tanbir M, Ahamed B, Hossain MJ, Roy A, Shahriar M, Bhuiyan MA, Islam MR. Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review. CLINICAL PATHOLOGY (THOUSAND OAKS, VENTURA COUNTY, CALIF.) 2023; 16:2632010X231161222. [PMID: 36938514 PMCID: PMC10014419 DOI: 10.1177/2632010x231161222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Accepted: 02/15/2023] [Indexed: 03/16/2023]
Abstract
Scientists identified SARS-CoV-2 in December 2019 in Wuhan city of China. Soon after its identification, Covid-19 spreads almost everywhere. The World Health Organization (WHO) declared the Covid-19 outbreak as a pandemic on March 11, 2020. Countries are facing multiple waves due to the different variants of the coronavirus. Personal preventive measures, vaccines, and antiviral drugs are the approaches to control Covid-19. However, these approaches are being implemented in different countries at different levels because of the availability of personal protective measures and antiviral agents. The objective of this study was to evaluate the effectiveness of practicing measures to fight the Covid-19 pandemic. Here we searched relevant literature from PubMed and Scopus using the keywords such as personal protective measures, antiviral agents, and vaccine effectiveness. According to the present findings, protective measures were found comparatively less effective. Nevertheless, these measures can be used to limit the spreading of Covid-19. Antiviral agents can reduce the hospitalization rate and are more effective than personal protective measures. The most effective strategy against Covid-19 is early vaccination or multiple vaccination dose. The respective authorities should ensure equal distribution of vaccines, free availability of antiviral drugs, and personal protective measure in poor and developing countries. We recommend more studies to describe the effectiveness of practicing preventive measures and antiviral agents against recent variants of the coronavirus.
Collapse
Affiliation(s)
- Md Anamul Haque
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Md Tanbir
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Bulbul Ahamed
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | - Md Jamal Hossain
- Department of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh
| | - Arpita Roy
- Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, India
| | - Mohammad Shahriar
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| | | | - Md Rabiul Islam
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh
| |
Collapse
|